Teng Long

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-2781-3808

发表论文 6 篇 · 总被引 32 次 · h-index 4

代表论文

• Integrated optimization of ply number, layer thickness, and fiber angle for variable-stiffness composites using dynamic multi-fidelity surrogate model (2024 · Thin-Walled Structures · 被引 12)
• Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma (2023 · Journal of Hepatocellular Carcinoma · 被引 10)
• An optimization framework for composite structure design with bounded uncertainties (2024 · Structures · 被引 5)
• The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab (2024 · Frontiers in Immunology · 被引 4)
• Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD (2025 · iLiver · 被引 1)
• Proposing re-classification of bile duct cancer and intrahepatic cholangiocarcinoma: A suggested modification based on the WHO classification (2025 · European Journal of Surgical Oncology)